Skull Base Tumors

Tumors at the skull base involve delicate blood vessels, nerves and other structures. If left untreated, these conditions can lead to serious consequences, such as blindness and stroke. Fortunately, the University of Chicago Medicine offers aggressive treatment strategies that reduce these risks with the goal of preserving function and quality of life. Our multidisciplinary team of neurosurgeons, neuro-oncologists and radiation oncologists works with each patient, providing personalized care and attention to determine the best course of action. As a result, our patients benefit from the most advanced therapies, as well as the combined skill and collaborative decision-making of these experts.

Comprehensive Treatment

The University of Chicago Medicine is home to a comprehensive Brain Tumor Center, where renowned experts offer a full range of diagnostic and treatment options. Our neurosurgeons specialize in skull base surgical techniques, operating near the base of the skull while preserving healthy tissues and brain-stem functions.

» Learn more about the diagnosis and treatment of brain and spinal cord tumors.

Pediatric Brain Tumors

In addition to providing advanced therapies, experts in our Pediatric Brain and Spinal Cord Tumor Center address the unique challenges facing children with skull base tumors, such as their medical, emotional, social and developmental needs. Whenever possible, we use minimally invasive surgical techniques to promote faster healing. And, by working with both pediatric and adult patients, our neurosurgeons and neuro-oncologists are able to provide ongoing support and continuity of care.
» Learn more about our Pediatric Brain and Spinal Cord Tumor Center.

Ongoing Research

We never stop looking for innovative ways to treat complex cerebrovascular conditions, including skull base tumors with neurovascular involvement. Our physicians are members of national research groups, collaborating with experts from across the country to offer leading-edge treatments and promising clinical trials.